An Overview of Genetic and Environmental Risk of Autism
Spectrum Disorder
Jianjun Ou1, Ruiting Liu2, Yidong
Shen1, Kun Xia2, Jingping Zhao1
1Department of Psychiatry & Mental
Health Institute of the Second Xiangya Hospital, Central South
University, the China National
Clinical Research Center for Mental Health Disorders, National Technology
Institute of Psychiatry, Key Laboratory of Psychiatry and Mental Health of
Hunan Province, Changsha, Hunan, China
2Center for Medical Genetics and School of Life
Sciences, Central South University, Changsha, Hunan, China
Received
October 8, 2018; Accepted December 6, 2018
ABSTRACT
Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder typically
diagnosed in children in the first few years of life. Genetic studies have demonstrated
a moderate to high heritability of ASD, but only a limited number of single
nucleotide polymorphisms (SNPs) have been identified. Meanwhile, numerous
single de novo rare variants and copy
number variations have been detected in patients with ASD, which are likely
caused by environmental factors. Here we provide an overview of genetic and
environmental factors that may contribute to the risk of ASD and we recommend
that further study should be focused on both genes and environmental factors,
as well as their interactions with the expectation that epigenetic studies will
lead to understanding the link between the environment and risk of ASD.
KEYWORDS
Genetic association;environmental
risk factors; autism spectrum disorder
Copyright © 2019 by the Global
Clinical and Translational Research.
How to
cite this article:
Ou J, Liu R, Shen Y, Xia K, Zhao J. An overview on genetic and
environmental risk of Autism Spectrum Disorder. Glob Clin Transl
Res. 2019;1(1):37-44.
DOI:10.36316/gcatr.01.0005.
References
1. American
Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders
(DSM5), 5th ed. Washington, DC (US): American Psychiatric Association
Publishing; 2013.
2. Lai MC, Lombardo
MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.
3. Buescher
AV, Cidav Z, Knapp M, Mandell DS. Costs of autism spectrum disorders in the
United Kingdom and the United States. JAMA Pediatr. 2014; 168 (8):721-8.
4. Ou JJ,
Shi LJ, Xun GL, Chen C, Wu RR, Luo XR, et al. Employment and financial burden
of families with preschool children diagnosed with autism spectrum disorders in
urban China: results from a descriptive study. BMC Psychiatry. 2015;15:3.
5. Lotter
V. Epidemiology of autistic conditions in young children. Social psychiatry.
1966;1(3):124-35.
6. Elsabbagh
M, Divan G, Koh YJ, Kim YS, Kauchali S, Marcin C, et al. Global prevalence of
autism and other pervasive developmental disorders. Autism Res.
2012;5(3):160-79.
7. Kim YS,
Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, et al. Prevalence of autism
spectrum disorders in a total population sample. Am J Psychiatry.
2011;168(9):904-12.
8. Saemundsen
E, Magnusson P, Georgsdottir I, Egilsson E, Rafnsson V. Prevalence of autism
spectrum disorders in an Icelandic birth cohort. BMJ Open. 2013;3(6):e002748.
9. Russell
G, Rodgers LR, Ukoumunne OC, Ford T. Prevalence of parent-reported ASD and ADHD
in the UK: findings from the Millennium Cohort Study. J Autism Dev Disord.
2014; 44(1):31-40.
10. Baio J,
Wiggins L, Christensen DL, Maenner MJ, Daniels J, Warren Z, et al. Prevalence
of Autism Spectrum Disorder Among Children Aged 8 Years - Autism and
Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014.
Mmwr Surveill Summ. 2018;67(6):1-23.
11. Hansen
SN, Schendel DE, Parner ET. Explaining the increase in the prevalence of autism
spectrum disorders: the proportion attributable to changes in reporting
practices. JAMA Pediatr. 2015;169(1):56-62.
12. Herbert
MR. Contributions of the environment and environmentally vulnerable physiology
to autism spectrum disorders. Curr Opin Neurol. 2010; 23(2): 103-10.
13. Lyall K,
Croen L, Daniels J, Fallin MD, Ladd-Acosta C, Lee BK, et al. The changing
epidemiology of autism spectrum disorders. Annu Rev Public Health. 2017;
38:81-102.
14. Colvert
E, Tick B, McEwen F, Stewart C, Curran SR, Woodhouse E, et al. Heritability of
autism spectrum disorder in a UK population-based twin sample. JAMA Psychiatry.
2015; 72(5):415-23.
15. Sandin S,
Lichtenstein P, Kuja-Halkola R, Larsson H, Hultman CM, Reichenberg A. The
familial risk of autism. JAMA. 2014;311(17):1770-7.
16. Gaugler
T, Klei L, Sanders SJ, Bodea CA, Goldberg AP, Lee AB, et al. Most genetic risk
for autism resides with common variation. Nat Genet. 2014;46(8):881-5.
17. Wang K,
Zhang HT, Ma DQ, Bucan M, Glessner JT, Abrahams BS, et al. Common genetic
variants on 5p14.1 associate with autism spectrum disorders. Nature.
2009;459(7246): 528-33.
18. Sebat J,
Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, et al. Strong
association of de novo copy number mutations with autism. Science. 2007;316
(5823):445-9.
19. O'Roak
BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome
sequencing in sporadic autism spectrum disorders identifies severe de novo
mutations. Nat Genet. 2011;43(6):585-9.
20. Yuen RK,
Thiruvahindrapuram B, Merico D, Walker S, Tammimies K, Hoang N, et al.
Whole-genome sequencing of quartet families with autism spectrum disorder. Nat
Med. 2015;21(2):185-91.
21. State MW,
Sestan N. The emerging biology of autism spectrum disorders. Science.
2012;337(6100): 1301-3.
22. Weiss LA,
Arking DE, Consortium JHA. A genome-wide linkage and association scan reveals
novel loci for autism. Nature. 2009;461(7265):802-U62.
23. Anney R,
Klei L, Pinto D, Regan R, Conroy J, Magalhaes TR, et al. A genome-wide scan for
common alleles affecting risk for autism. Hum Mol Genet. 2010;19(20):4072-82.
24. Anney R,
Klei L, Pinto D, Almeida J, Bacchelli E, Baird G, et al. Individual common
variants exert weak effects on the risk for autism spectrum disorders. Hum Mol
Genet. 2012; 21(21):4781-92.
25. Cross-Disorder
Group of the Psychiatric Genomics C. Identification of risk loci with shared
effects on five major psychiatric disorders: a genome-wide analysis. Lancet.
2013; 381(9875):1371-9.
26. Xia K,
Guo H, Hu Z, Xun G, Zuo L, Peng Y, et al. Common genetic variants on 1p13.2
associate with risk of autism. Mol Psychiatry. 2014;19(11):1212-9.
27. Glessner
JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S, et al. Autism genome-wide copy
number variation reveals ubiquitin and neuronal genes. Nature. 2009;459(7246):
569-73.
28. Pinto D,
Pagnamenta AT, Klei L, Anney R, Merico D, Regan R, et al. Functional impact of
global rare copy number variation in autism spectrum disorders. Nature.
2010;466 (7304):368-72.
29. Levy D,
Ronemus M, Yamrom B, Lee YH, Leotta A, Kendall J, et al. Rare de novo and
transmitted copy-number variation in autistic spectrum disorders. Neuron.
2011;70(5):886-97.
30. Marshall
CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, et al. Structural variation
of chromosomes in autism spectrum disorder. Am J Hum Genet. 2008; 82(2):477-88.
31. Guo H,
Peng Y, Hu Z, Li Y, Xun G, Ou J, et al. Genome-wide copy number variation
analysis in a Chinese autism spectrum disorder cohort. Sci Rep. 2017;7: 44155.
32. Iossifov
I, O'Roak BJ, Sanders SJ, Ronemus M, Krumm N, Levy D, et al. The contribution
of de novo coding mutations to autism spectrum disorder. Nature. 2014;515
(7526): 216-21.
33. Muers M.
Human genetics: Fruits of exome sequencing for autism. Nature reviews Genetics.
2012;13 (6):377.
34. Wang TY,
Guo H, Xiong B, Stessman HAF, Wu HD, Coe BP, et al. De novo genic mutations
among a Chinese autism spectrum disorder cohort. Nature Communications. 2016;
7: 13316.
35. RK CY,
Merico D, Bookman M, J LH, Thiruvahin-drapuram B, Patel RV, et al. Whole genome
sequencing resource identifies 18 new candidate genes for autism spectrum disorder.
Nat Neurosci. 2017; 20(4):602-11.
36. Kim YS,
Leventhal BL. Genetic epidemiology and insights into interactive genetic and
environmental effects in autism spectrum disorders. Biol Psychiatry.
2015;77(1): 66-74.
37. Sealey
LA, Hughes BW, Sriskanda AN, Guest JR, Gibson AD, Johnson-Williams L, et al.
Environmental factors in the devleopment of autism spectrum disorders. Environ
Int. 2016;88:288-98.
38. Hallmayer
J, Cleveland S, Torres A, Phillips J, Cohen B, Torigoe T, et al. Genetic
Heritability and Shared Environmental Factors Among Twin Pairs With Autism.
Arch Gen Psychiat. 2011;68(11):1095-102.
39. Mandy W,
Lai MC. Annual Research Review: The role of the environment in the
developmental psychopathology of autism spectrum condition. J Child Psychol
Psychiatry. 2016; 57(3):271-92.
40. Glasson
EJ, Bower C, Petterson B, de Klerk N, Chaney G, Hallmayer JF. Perinatal factors
and the development of autism: a population study. Arch Gen Psychiatry. 2004;
61 (6):618-27.
41. Hultman
CM, Sandin S, Levine SZ, Lichtenstein P, Reichenberg A. Advancing paternal age
and risk of autism: new evidence from a population-based study and a
meta-analysis of epidemiological studies. Mol Psychiatry. 2011;16(12): 1203-12.
42. Sandin S,
Hultman CM, Kolevzon A, Gross R, MacCabe JH, Reichenberg A. Advancing maternal
age is associated with increasing risk for autism: a review and meta-analysis.
J Am Acad Child Psy. 2012; 51(5):477-86.
43. Kong A,
Frigge ML, Masson G, Besenbacher S, Sulem P, Magnusson G, et al. Rate of de
novo mutations and the importance of father's age to disease risk. Nature.
2012;488 (7412):471-5.
44. Buizer-Voskamp
JE, Blauw HM, Boks MPM, van Eijk KR, Veldink JH, Hennekam EAM, et al. Increased
paternal age and the influence on burden of genomic copy number variation in
the general population. Hum Genet. 2013;132 (4): 443-50.
45. Chess S.
Autism in children with congenital rubella. J Autism Child Schizophr.
1971;1(1):33-47.
46. Hutton J.
Does Rubella Cause Autism: A 2015 Reappraisal? Front Hum Neurosci. 2016;10:25.
47. Knuesel
I, Chicha L, Britschgi M, Schobel SA, Bodmer M, Hellings JA, et al. Maternal
immune activation and abnormal brain development across CNS disorders. Nat Rev
Neurol. 2014;10(11):643-60.
48. Estes ML,
McAllister AK. Immune mediators in the brain and peripheral tissues in autism spectrum
disorder. Nat Rev Neurosci. 2015;16(8):469-86.
49. Patterson
PH. Immune involvement in schizophrenia and autism: etiology, pathology and
animal models. Behav Brain Res. 2009;204(2):313-21.
50. Spann MN,
Sourander A, Surcel HM, Hinkka-Yli-Salomaki S, Brown AS. Prenatal toxoplasmosis
antibody and childhood autism. Autism Res. 2017; 10(5): 769-77.
51. Estes ML, McAllister AK. Maternal immune
activation: Implications for neuropsychiatric disorders. Science. 2016;
353(6301):772-7.
52. Beards S,
Gayer-Anderson C, Borges S, Dewey ME, Fisher HL, Morgan C. Life events and
psychosis: a review and meta-analysis. Schizophr Bull. 2013; 39 (4):740-7.
53. Holtzman
CW, Trotman HD, Goulding SM, Ryan AT, Macdonald AN, Shapiro DI, et al. Stress
and neurodevelopmental processes in the emergence of psychosis. Neuroscience.
2013;249:172-91.
54. van
Winkel R, Stefanis NC, Myin-Germeys I. Psychosocial stress and psychosis. A
review of the neurobiological mechanisms and the evidence for gene-stress
interaction. Schizophr Bull. 2008;34(6): 1095-105.
55. Ward AJ.
A comparison and analysis of the presence of family problems during pregnancy
of mothers of "autistic" children and mothers of normal children.
Child Psychiatry Hum Dev. 1990;20(4):279-88.
56. Beversdorf
DQ, Manning SE, Hillier A, Anderson SL, Nordgren RE, Walters SE, et al. Timing
of prenatal stressors and autism. J Autism Dev Disord. 2005; 35(4):471-8.
57. Maimburg RD,
Vaeth M. Perinatal risk factors and infantile autism. Acta Psychiatr Scand.
2006;114(4): 257-64.
58. Rai D, Lee BK, Dalman C, Golding J, Lewis G,
Magnusson C. Parental depression, maternal antidepressant use during
pregnancy, and risk of autism spectrum disorders: population based case-control
study. BMJ. 2013;346:f2059.
59. El
Marroun H, White TJ, van der Knaap NJ, Homberg JR, Fernandez G, Schoemaker NK,
et al. Prenatal exposure to selective serotonin reuptake inhibitors and social
responsiveness symptoms of autism: population-based study of young children. Br
J Psychiatry. 2014;205(2):95-102.
60. Croen LA,
Grether JK, Yoshida CK, Odouli R, Hendrick V. Antidepressant Use During
Pregnancy and Childhood Autism Spectrum Disorders. Arch Gen Psychiat. 2011;68
(11): 1104-12.
61. Sorensen
MJ, Gronborg TK, Christensen J, Parner ET, Vestergaard M, Schendel D, et al.
Antidepressant exposure in pregnancy and risk of autism spectrum disorders.
Clin Epidemiol. 2013;5:449-59.
62. Hviid A,
Melbye M, Pasternak B. Use of Selective Serotonin Reuptake Inhibitors during
Pregnancy and Risk of Autism. New Engl J Med. 2013;369 (25): 2406-15.
63. Gardener
H, Spiegelman D, Buka SL. Prenatal risk factors for autism: comprehensive
meta-analysis. Br J Psychiatry. 2009;195(1):7-14.
64. Langridge
AT, Glasson EJ, Nassar N, Jacoby P, Pennell C, Hagan R, et al. Maternal
conditions and perinatal characteristics associated with autism spectrum
disorder and intellectual disability. PLoS One. 2013; 8(1):e50963.
65. Mahoney
AD, Minter B, Burch K, Stapel-Wax J. Autism spectrum disorders and prematurity:
a review across gestational age subgroups. Adv Neonatal Care. 2013;13 (4):
247-51.
66. Limperopoulos
C, Bassan H, Sullivan NR, Soul JS, Robertson RL, Jr., Moore M, et al. Positive
screening for autism in expreterm infants: prevalence and risk factors.
Pediatrics. 2008;121(4):758-65.
67. Johnson
S, Hollis C, Kochhar P, Hennessy E, Wolke D, Marlow N. Autism spectrum
disorders in extremely preterm children. Journal of Pediatrics. 2010; 156
(4):525-U27.
68. Schieve
LA, Tian LH, Baio J, Rankin K, Rosenberg D, Wiggins L, et al. Population
attributable fractions for three perinatal risk factors for autism spectrum
disorders, 2002 and 2008 autism and developmental disabilities monitoring
netwo-rk. Ann Epidemiol. 2014;24(4):260-6.
69. Hultman
CM, Sparen P, Cnattingius S. Perinatal risk factors for infantile autism.
Epidemiology. 2002; 13(4):417-23.
70. Feng XL,
Xu L, Guo Y, Ronsmans C. Factors influencing rising caesarean section rates in
China between 1988 and 2008. Bulletin of the World Health Organization. 2012;90
(1):30-9.
71. Guinchat
V, Thorsen P, Laurent C, Cans C, Bodeau N, Cohen D. Pre-, peri- and neonatal
risk factors for autism. Acta Obstet Gynecol Scand. 2012;91(3):287-300.
72. Dickerson
AS, Rahbar MH, Bakian AV, Bilder DA, Harrington RA, Pettygrove S, et al. Autism
spectrum disorder prevalence and associations with air concentrations of lead,
mercury, and arsenic. Environ Monit Assess. 2016;188 (7): 407.
73. Fujiwara
T, Morisaki N, Honda Y, Sampei M, Tani Y. Chemi-cals, Nutrition, and Autism
Spectrum Disorder: A Mini-Review. Front Neurosci. 2016;10:174.
74. Kalkbrenner
AE, Schmidt RJ, Penlesky AC. Environmental chemical exposures and autism
spectrum disorders: a review of the epidemiological evidence. Curr Probl
Pediatr Adolesc Health Care. 2014; 44(10):277-318.
75. Flores-Pajot
MC, Ofner M, Do MT, Lavigne E, Villeneuve PJ. Childhood autism spectrum
disorders and exposure to nitrogen dioxide, and particulate matter air
pollution: A review and meta-analysis. Environ Res. 2016;151:763-76.
76. Gong T,
Dalman C, Wicks S, Dal H, Magnusson C, Lundholm C, et al. Perinatal exposure to
traffic-related air pollution and autism
spectrum disorders. Environ Health Perspect. 2017;125(1):119-26.
77. Sealey
LA, Hughes BW, Pestaner JP, Steinemann A, Pace DG, Bagasra O. Environmental
factors may contribute to autism development and male bias: Effects of fragrances
on developing neurons. Environmental Research. 2015;142:731-8.
78. Knickmeyer
RC, Baron-Cohen S. Fetal testosterone and sex differences in typical social
development and in autism. J Child Neurol. 2006;21(10):825-45.
79. Tordjman
S, Somogyi E, Coulon N, Kermarrec S, Cohen D, Bronsard G, et al. Gene x
Environment interactions in autism spectrum disorders: role of epigenetic
mechanisms. Front Psychiatry. 2014;5:53.
80. Hertz-Picciotto
I, Croen LA, Hansen R, Jones CR, van de Water J, Pessah IN. The CHARGE study:
an epidemiologic investigation of genetic and environmental factors contributing
to autism. Environ Health Perspect. 2006;114(7): 1119 -25.
81. Kim D,
Volk H, Girirajan S, Pendergrass S, Hall MA, Verma SS, et al. The joint effect
of air pollution exposure and copy number variation on risk for autism. Autism
Res. 2017;10 (9):1470-80.